Elevance Health (NYSE:ELV – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it compare to its rivals? We will compare Elevance Health to similar companies based on the strength of its analyst recommendations, profitability, risk, earnings, valuation, dividends and institutional ownership.
Earnings & Valuation
This table compares Elevance Health and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Elevance Health | $201.83 billion | $5.66 billion | 17.01 |
| Elevance Health Competitors | $21.21 billion | $301.67 million | -3.62 |
Elevance Health has higher revenue and earnings than its rivals. Elevance Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
Elevance Health has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Elevance Health’s rivals have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.
Profitability
This table compares Elevance Health and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elevance Health | 2.55% | 14.97% | 5.31% |
| Elevance Health Competitors | -1.05% | -139.10% | -2.48% |
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Elevance Health and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elevance Health | 0 | 7 | 16 | 0 | 2.70 |
| Elevance Health Competitors | 1889 | 7760 | 13425 | 837 | 2.55 |
Elevance Health presently has a consensus target price of $458.91, indicating a potential upside of 15.05%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.45%. Given Elevance Health’s rivals higher possible upside, analysts clearly believe Elevance Health has less favorable growth aspects than its rivals.
Dividends
Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.5% and pay out 24.9% of their earnings in the form of a dividend. Elevance Health has raised its dividend for 14 consecutive years.
Institutional and Insider Ownership
89.2% of Elevance Health shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Elevance Health beats its rivals on 10 of the 15 factors compared.
Elevance Health Company Profile
Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.
